VivoSim Labs (VIVS) Short Interest Ratio & Short Volume

Short interest is the volume of VivoSim Labs shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 221,800 shares of VIVS short. 8.63% of VivoSim Labs' shares are currently sold short. Learn More on VivoSim Labs' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VIVS shares currently have a short interest ratio of 1.0. Learn More on VivoSim Labs's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.63% of VivoSim Labs' floating shares are currently sold short.

VivoSim Labs saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 221,800 shares, an increase of 485.2% from the previous total of 37,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

VivoSim Labs currently has issued a total of 2,600,000 shares. Some of VivoSim Labs' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. VivoSim Labs currently has a public float of 2,570,000 shares.

8.63% of VivoSim Labs' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to VivoSim Labs: Adaptimmune Therapeutics PLC (8.70%), Iterum Therapeutics PLC (3.14%), PyroGenesis Canada Inc. (0.17%), Kezar Life Sciences, Inc. (12.21%), Dare Bioscience, Inc. (1.85%), Cadrenal Therapeutics, Inc. (0.84%), Klotho Neurosciences, Inc. (4.84%), Rein Therapeutics Inc. (0.10%), Moleculin Biotech, Inc. (8.50%), Exicure, Inc. (1.84%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks.

Short selling VIVS is an investing strategy that aims to generate trading profit from VivoSim Labs as its price is falling. VIVS shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for VivoSim Labs occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VIVS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIVS, twice per month. The most recent reporting period available is September, 15 2025.